ConferencePoster
 (2016)

A single, low dose of a current Good Manufacturing Practive (cGMP) recombinant BCG vaccine confers protection against human respiratory syncytial virus (hRSV) infection and lung pathology in mice

Céspedes, P., Rey-Jurado, E., Espinoza, J., Rivera, C., Bueno, S., and Kalergis A.